Colibactin toxin linked to rise in early-onset bowel cancer
Researchers suspect a bacterial toxin called colibactin drives the doubling of early-onset bowel cancer cases seen over the last two decades. This toxin produces mutations that appear three times more frequently in tumours from people under 40 than in those…
